Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia (Q47868737)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 2004

Language	Label	Description	Also known as
English	Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia	scientific article published in May 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

1 reference

based on heuristic

inferred from title

chronic myelomonocytic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Saliba RM

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

Richard E Champlin

9

object named as

Champlin RE

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

3

object named as

Giralt SA

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

author name string

Mittal P

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

Shahjahan M

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

Cohen AI

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

Karandish S

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

Onida F

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

Beran M

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

de Lima M

10

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

33

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

10

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

1005-1009

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

The Analysis of Failure Times in the Presence of Competing Risks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Pathogenesis and management of idiopathic myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Allogeneic bone marrow transplantation for primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Chronic myelomonocytic leukemia: natural history and prognostic determinants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

21 January 2018

Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-myeloablative transplants for malignant disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704472

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704472

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15048141

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47868737&oldid=2208909323"